InvestorsHub Logo
Followers 7
Posts 1182
Boards Moderated 0
Alias Born 05/09/2019

Re: DIVEROTC1 post# 40919

Tuesday, 07/02/2019 9:27:09 AM

Tuesday, July 02, 2019 9:27:09 AM

Post# of 112222
Comparable companies: from MarketWatch.

I am not Hymeeto, but hopefully I can help.

Some of the players in epigenetics market Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), New England Biolabs, Inc. (U.S.), Merck & Co. (U.S.), Sigma-Aldrich Corporation (U.S.), Genedata AG(Switzerland), Cayman chemical company (U.S), Active Motif (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Diagenode, Inc. (Belgium), Zymo Research Corporation (U.S.). and Episona Inc. (U.S).

https://www.marketwatch.com/press-release/epigenetics-market-2018-global-analysisresearchreviewapplications-and-forecast-to-2023-2018-12-19

Illumina trades at $370 PPS. ($ILMN)
(Of course they have over 7k employees)

I would research more but I am driving. Hopefully Hymeeto responds too.

Everything said here is my opinion and should not be taken as investment advice.

“The safest way to double your money is to fold it over once and put it in your pocket.” – Frank McKinney Hubbard, humorist

“The time of maximum pessimism is the best